“Safety and Efficacy of Combination Therapy of Upadacitinib and Biologic Agents for Treatment-Resistant Psoriasis and Psoriatic Arthritis” (2024) SKIN The Journal of Cutaneous Medicine, 8(3), pp. 1574–1580. doi:10.25251/skin.8.3.17.